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Abstract
The Disease Control Priorities (DCP) publications have pioneered new ways of thinking about investing in 
health. We agree with Norheim, that a useful first step to advance efforts to translate DCP’s global evidence 
into local health priorities, is to develop a clear Theory of Change (ToC). However, a ToC that aims to define 
how global evidence (DCP and others) can be used to inform national policy is too narrow an undertaking. We 
propose efforts should be directed towards developing a ToC to define how to support progressive institutional 
development to deliver on universal health coverage (UHC), putting the client at the center. Enhancing efforts 
to meet the new global health imperatives requires a shift in focus of attention to move radically from global to 
local. In order to achieve this we need to reorganize the nature of technical assistance (TA) along three major 
lines (1) examine and act to clarify the mandates and roles to be played by multilateral normative and convening 
agencies, (2) ensure detailed understanding of local institutions, their needs and their demands, and (3) provide 
TA over time and in trust with local counterparts. This last requirement implies the need for long-term local 
presence as well as an international network of expertise centers, to share scarce technical capabilities as well as 
to learn together across country engagements. Financing will need to be reorganized to incentivize and support 
demand-led capacity strengthening. 
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The Disease Control Priorities (DCP) publications1-3 have pioneered new ways of thinking about investing in health (economic benefits of good health as well 
as the importance of making choices in what to invest in). 
The third edition has adapted to critiques that it was too 
narrowly focused on cost-effectiveness and has incorporated 
additional considerations – it has broadened the range of 
health concerns to be evaluated – and it has provided policy 
advice on options for assembling essential health benefits 
packages for resource-constrained settings. However, to date, 
while editions 1 and 2 had some impact at the global level, 
examples of use among national policy-makers have been 
limited.4 Along with the global publication of DCP3, focused 
efforts have been put in place to translate contents to country-
level uses in Afghanistan and Ethiopia[1]. Clearly, additional 
efforts are required to translate the rich evidence included in 
DCP into national policy, to ensure global evidence has vital 
local meaning.5 
We agree with Norheim,6 that a useful first step to advance 
efforts to translate DCP’s global evidence into local health 
priorities is to develop a clear Theory of Change (ToC) that 
articulates the desired long-term country outcomes. We also 
concur with Norheim’s detailed assumptions about the need 
for local capacity and institutions as requirements for success. 
Where we differ from Norheim is in emphasis. If the aim is 
for long-term country outcomes (better governance of health 
systems for efficiency and equity) then we need a ToC that 
emphasizes the primary process – development of public 
capacity. While the use of excellent global knowledge is of 
great importance, it is a source of knowledge as opposed to 
the process of change we are interested in.
Once we put the client at the center, a broader range of 
critical assumptions and intervention issues become explicit 
– and the pathways to the outcomes we are looking for (better 
governance of health systems for efficiency and equity) are 
made more realistic. In this commentary we try and broaden 
the frame for discussion by arguing that efforts to integrate 
global evidence into priority-setting need to be seen within 
a broader context of supporting local capacity to undertake a 
range of functions to realize health financing reform. 
The changing demography, burden of disease and domestic 
and international agenda for health mean that countries need 
much more complex health systems and a wider range of 
capacities to govern them. Countries must plan, within fiscal 
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space constraints, to diagnose and treat a far wider range of 
conditions for a broader segment of the population. They 
must also financially protect health care users; regulate and 
partner with private sector providers; protect the public from 
relevant risk factors (such as poor diet, air pollution, misuse 
of alcohol, and road traffic accidents); and build capacity 
to detect and respond to outbreaks of potentially epidemic 
diseases. 
As opposed to having processes led by those intent on 
transferring a body of global knowledge or a specific set of 
technologies (eg, health technology assessment or strategic 
purchasing), it might be better to partner with national 
governments to strengthen or build institutions by asking first 
“what are the existing capabilities?” and “what is needed?” The 
desired outcome must be locally sustainable, multi-functional, 
learning institutions – able to govern national health systems 
effectively, and within existing resource constraints. In short, 
we believe it may be more effective to develop a ToC to support 
progressive institutional development to deliver on universal 
health coverage (UHC). This puts the client at the center, as 
opposed to the knowledge provider. But how to get there?
Global knowledge can only be used by countries if there 
are the institutions, processes and capacities to be able 
to translate it into a series of decisions – implement – and 
reiterate those decisions dynamically over time. This is why 
thinking deeply about the role of evidence at country-level – 
how to support institutions to make decisions and implement 
these decisions  is critical. This involves a reimagining of the 
role of national governments in resource-constrained settings 
to have a broader and more complex function. Specifically, 
this means governments must have capabilities in priority-
setting (the focus of DCP), but also health financing, equity 
analysis, private sector regulation and strategic purchasing, 
information systems for evidence driven policy-making, 
and accountability and inclusion of a wide range of societal 
interests.7 The global agenda goes from driving towards 
globally established targets (eg, reduction of under 5 mortality 
or HIV transmission rates) to national development of 
systems, and becomes domestic and political.
Our proposed conceptualization should consider how 
development assistance for health (DAH) can better support 
national governments to emerge as competent, dynamic, 
sovereign agencies for health promotion and protection while 
pursuing results.
Technical assistance (TA) has long been a major component 
of aid – reflecting a desire to transfer technology/knowledge 
and not just financial resources. But TA is often provided 
piecemeal, with short-term perspectives and across a wide 
and uncoordinated range of issues that governments have 
not necessarily prioritized, often occurring without clear 
strategies for transfer or sustainability.
(1)	 At the country level – the institutional arrangements 
need to be clear and the loci of responsibility established. 
Defining which national institute or unit should be 
supported with TA is important – this would lead to all 
relevant TA in one thematic area being delivered to the 
same unit by different agencies. This would allow a better 
overview, comparison of worth and coordination of TA 
by national governments.
(2)	 TA should be demand-driven as opposed to supply-
driven. TA is too often driven by the mandate and or 
technical position of the TA providing institution (with 
control of TA resources). No matter how technically 
correct the perceived priorities for what a national 
government should be doing – it cannot do everything. If 
the national government has not prioritized a particular 
issue, no amount of excellent TA will drive purposeful 
processes leading to decisions and implementation. In 
order to be effective, TA should be provided to answer 
the questions the national government is interested 
to answer – and to collectively find an appropriate 
compromise within political and operating constraints 
(as opposed to upholding “global recommendations” 
without consideration of local factors or feasibility). This 
will require expertise but also real-world experience 
from TA providers. Countries may want to source TA 
from actors within the region or from other countries 
with recent relevant experience as opposed to Western 
experts.
(3)	 Such TA needs to be provided by a trusted partner. TA 
providing partners might set up long term relationships 
with the institution in question – responding to a 
variety of requests and needs over time as the institution 
progresses down the pathway of building capacities and 
defining and answering critical questions.
(4)	 Plans for reform of World Health Organization (WHO) 
country offices (under the new 13th General Programme 
of Work) include a reformulation of their role and 
competence in-country.8 The WHO should focus less 
on providing TA and more on helping to identify critical 
needs/priorities, the unit that is the loci of responsibility 
and potential partners to provide TA (ie, work on the 
demand-side not supply-side as well). Under such 
operating conditions WHO would then have greater 
legitimacy to convene networks of providers involved in 
such long term support processes – and allow them to 
exchange expertise, staff and learning (to enhance their 
TA support value) - and concretize this learning as part 
of WHO’s normative processes.
(5)	 Much TA and capacity support is provided in the form 
of training and or advice to individuals. Too little is 
considered in terms of building institutions. In addition 
to specific technologies – TA providers need to look at the 
legal mandate of institutions – administrative processes – 
board oversight – technical resources and staffing issues. 
It is critical that national governments can source useful 
and appropriate TA for what is needed and demanded over 
time. There is some good news: 
• Development partners, including international 
organizations, bilateral, regional and multilateral 
banks, foundations and others, are increasingly offering 
support to strengthen national institutional capacity 
for evidence-informed decision-making for UHC. This 
includes defining strategic support functions for UHC 
and building global knowledge[2]. 
• Bilateral and multilateral donors are united in their 
awareness that they can no longer only focus on 
achieving global health outcomes because of unintended 
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impacts on broader health system performance. The 
Global Financing Facility in support of Every Women 
Every Child (GFF) is a relatively new initiative that aims 
to do business differently – explicitly leveraging grant 
investments to elicit government leadership, strategic 
planning and domestic resource mobilization. The GFF 
shows considerable promise.9
• The US Agency for International Development (USAID) 
has recently selected Results for Development to lead 
a new 5-year global initiative: The Health Systems 
Strengthening Accelerator (HSS Accelerator). This 
global platform will “connect locally-driven health 
system reforms and innovations with global knowledge, 
enhance local institutions devoted to ongoing system 
strengthening, and accelerate countries’ journeys to self-
reliant health systems.”10 
Donors realize that DAH must not cause harm and if possible 
must realize meaningful benefits for the health of ordinary 
people, whilst propelling health system development forward. 
The initiatives listed above are a step in the right direction, 
but they remain fragmented and uncoordinated. The “whole 
of DAH” impact at country level is not sufficiently considered 
and no one takes responsibility for it. New initiatives are 
promising and indicative of increased will to grapple with 
these issues. However, regarding support to the emergence of 
competent national health systems, able to drive programmes 
of reform over time, much still needs to be done.
The shifts in strategically connecting global knowledge, 
the role of global convening agencies and new approaches to 
the provision of TA, that we are proposing, is not happening 
sufficiently. What is sorely needed is a coordinated approach 
and platform with a shared ToC for TA for institutional 
capacity building to support health sector reform. Some 
of this thinking has already been outlined in the Bangkok 
Statement: Priority Setting for Universal Health Coverage.11
While there are undoubtedly problems with how TA for 
priority-setting and health systems support more generally 
is currently offered, an opportunity clearly exists. There 
is an urgent need to work together to create joined up aid 
investments to ensure progress on health and domestic 
capacity at the same time – and across a range of health 
concerns. We think further work is needed to elucidate the 
role of global knowledge, global institutions (such as WHO 
and the World Bank) and centers of expertise (TA providers). 
We also believe redesign must pivot around national 
institutional imperatives and not global health interests. TA 
– and the interests of TA providers – should be aligned with 
national interests.
Governments of resource-constrained countries, global 
health financiers and experienced knowledge partners must 
work better together to define partnerships of genuine use 
to national governments, and to network them to learn 
collectively and expand impact across country borders. 
We believe there is a role for DCP’s global evidence, and that 
through translation efforts at country level, DCP can play an 
important role in effecting resource allocation decisions for 
health, and thereby produce more health for the money. But 
for this outcome to become a reality, it will require broader 
coordination efforts by a range of partners, including WHO, 
the World Bank and GFF, other Global Funds (GAVI and 
GFATM) and USAID’s HSS Accelerator, to define roles and to 
ensure emphasis on coordination and local ownership.
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Endnotes
[1] For Ethiopia see: https://www.uib.no/en/rg/globpri/110822/gates-funds-
ethiopian-health-priorities-project-3-million. 
For Afghanistan see: https://www.lshtm.ac.uk/newsevents/expert-opinion/
developing-new-basic-package-health-services-afghanistan-0. 
[2] For example DCP, the International Decision Support Initiative (iDSI), the 
Strategic Purchasing Africa Resource Center (SPARC), the Joint Learning 
Network (JLN), the Primary Health Care Performance Initiative (PHCPI), to 
name a few.
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